Kincell Bio
Your CDMO Partner from Clinical to Commercial
94 employees · est. 2023 · Durham, United States
Be Biopharma is the older company (2020 vs 2023); Kincell Bio is the larger of the two.
Side-by-Side Comparison
| Metric | Be Biopharma | Kincell Bio |
|---|---|---|
| Founded | ||
| Founded | 2020 older | 2023 |
| Headquarters | ||
| Headquarters | Cambridge, United States | Durham, United States |
| Employees | ||
| Employees | 46 | 94 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Pharmaceutical | Biopharma, Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series C | Unknown |
| Total Funding | ||
| Total Funding | $356.00M | $58.00M |
| Funding Rounds | ||
| Funding Rounds | 4 | 2 |
| Services | ||
| Services | Development of B Cell Medicines, Clinical Trial Management, Preclinical Research in Protein-Based Therapies | CMC Roadmap & Development, Analytical Development & Methods, Characterization & Release Testing, Early & Late Phase Process Development, Clinical & Commercial GMP Manufacturing, Tech Transfer In Playbook |
| Target Customers | ||
| Target Customers | Patients with Hemophilia B, Patients with Hypophosphatasia, Healthcare Providers, Medical Researchers | Biotechnology Companies, Cell Therapy Developers, Pharmaceutical Companies, Research Institutions |
| Taxonomy | ||
| Taxonomy | Engineered B Cell Medicines, Hemophilia B Treatment, Genetic Disease Therapies, Cancer Cell Therapy, Biotech Research, Cell Therapies, B Cell Engineering, Biopharmaceuticals, Innovative Therapeutics, Patient-Centric Approach, Cell Therapy Manufacturing, Medical Biotechnology | Cell Therapy CDMO, Autologous Cell Therapies, Allogeneic Cell Therapies, Clinical Manufacturing, Commercial Manufacturing, CMC Strategies, GMP-compliant Manufacturing, Process Development, Analytical Development, Assay Optimization, Inspection Readiness, CAR-T Therapies, CAR-M Therapies, CAR-NK Therapies, TCR-T Therapies |
| Website | ||
| Website | be.bio | kincellbio.com |
About Be Biopharma
Be Biopharma, founded in 2020, is a pioneering player in the Biopharma and Biotechnology sectors. The company's innovative approach is encapsulated in its slogan, "Engineered B cells as medicines," highlighting its commitment to developing novel treatments to significantly enhance patient outcomes....
About Kincell Bio
Kincell Bio, founded in 2023, operates as a specialized cell therapy CDMO in the Biopharma, Biotechnology, and Pharmaceutical industries, with headquarters in the United States. Their slogan, Your CDMO Partner from Clinical to Commercial, encapsulates their mission of supporting autologous and allog...
We will tell you when either one moves
BounceWatch watches Be Biopharma and Kincell Bio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Be Biopharma and Kincell Bio — by email.
Frequently Asked Questions
Compare Be Biopharma with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Be Biopharma on 9 Jun 2026, and Kincell Bio on 4 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.